Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics

Pharmacogenomics Journal

Volumn 15, Issue 2, 2015, Pages 119-126

  Sadhasivam, S ^a   Chidambaran, V ^a   Zhang, X ^a   Meller, J ^a   Esslinger, H ^a   Zhang, K ^a   Martin, L J ^a   McAuliffe, J ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; MORPHINE; MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; NARCOTIC ANALGESIC AGENT;

ABCB1 GENE; ADOLESCENT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHARMACOGENETICS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RESPIRATION DEPRESSION; RISK ASSESSMENT; TONSILLECTOMY; CHEMICALLY INDUCED; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PAIN; PROCEDURES; RESPIRATORY FAILURE; RISK;

ALLELES; ANALGESICS, OPIOID; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LENGTH OF STAY; MALE; MORPHINE; P-GLYCOPROTEINS; PAIN; PHARMACOGENETICS; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY; RISK;

EID: 84925650964     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2014.56     Document Type: Article

References (38)

1. Erickson BK, Larson DR St, Sauver JL, Meverden RA, Orvidas LJ. Changes in incidence and indications of tonsillectomy and adenotonsillectomy 1970-2005. Otolaryngol Head Neck Surg 2009; 140: 894-901.
2. Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 2013; 368: 2366-2376.
3. Brouillette RT. Let's CHAT about adenotonsillectomy. N Engl J Med 2013; 368: 2428-2429.
4. Goldman JL, Baugh RF, Davies L, Skinner ML, Stachler RJ, Brereton J et al. Mortality and major morbidity after tonsillectomy: etiologic factors and strategies for prevention. Laryngoscope 2013; 123: 2544-2553.
5. Food and Drug Administration. Safety review update of codeine use in children; new boxed warning and contraindication on use after tonsillectomy and/or adenoidectomy. FDA Drug Safety Communication, 2013; http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm.
6. Biavati MJ, Manning SC, Phillips DL. Predictive factors for respiratory complications after tonsillectomy and adenoidectomy in children. Arch Otolaryngol Head Neck Surg 1997; 123: 517-521.
7. Rosen GM, Muckle RP, Mahowald MW, Goding GS, Ullevig C. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated?. Pediatrics 1994; 93: 784-788.
8. Lasky T, Greenspan J, Ernst FR, Gonzalez L. Morphine use in hospitalized children in the United States: a descriptive analysis of data from pediatric hospitalizations in 2008. Clin Ther 2012; 34: 720-727.
9. Brown KA, Laferriere A, Lakheeram I, Moss IR. Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. Anesthesiology 2006; 105: 665-669.
10. Zhang Z, Xu F, Zhang C, Liang X. Activation of opioid mu receptors in caudal medullary raphe region inhibits the ventilatory response to hypercapnia in anesthetized rats. Anesthesiology 2007; 107: 288-297.
11. Pattinson KT. Opioids and the control of respiration. Br J Anaesth 2008; 100: 747-758.
12. Pattinson KT, Governo RJ, MacIntosh BJ, Russell EC, Corfield DR, Tracey I et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci 2009; 29: 8177-8186.
13. Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M et al. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Cin Pharmacol 2002; 54: 592-603.
14. Park HJ, Shinn HK, Ryu SH, Lee HS, Park CS, Kang JH. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin Pharmacol Ther 2007; 81: 539-546.
15. Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA. Self-reported vs administrative race/ethnicity data and study results. Am J Public Health 2002; 92: 1471-1472.
16. Lalovic B, Phillips B, Risler LL, Howald W, Shen DD. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos 2004; 32: 447-454.
17. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23: 293-297.
18. Jensen MP, Smith DG, Ehde DM, Robinsin LR. Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 2001; 91: 317-322.
19. Nafiu OO, Shanks A, Abdo S, Taylor E, Tremper TT. Association of high body mass index in children with early post-tonsillectomy pain. Int J Pediatr Otorhinolaryngol 2013; 77: 256-261.
20. Sadhasivam S, Chidambaran V, Ngamprasertwong P, Esslinger HR, Prows C, Zhang X et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics 2012; 129: 832-838.
21. Stern C. The Hardy-Weinberg Law. Science 1943; 97: 137-138.
22. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007; 41: 400-406.
23. Ishikawa T, Tsuji A, Inui K, Sai Y, Anzai N, Wada M et al. The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 2004; 5: 67-99.
24. Crettol S, Deglon JJ, Besson J, Croquette-Krokar M, Hammig R, Gothuey I et al. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on metha-done plasma levels and response to treatment. Clin Pharmacol Ther 2006; 80: 668-681.
25. Paice JA, Gordon DB, Contreras J. The Joint Commission Sentinel Event Alert. Joint Comm 2012; 49: 1-5.
26. Kelly LE, Rieder M, van den Anker J, Malkin B, Ross C, Neely MN et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics 2012; 129: e1343-e1347.
27. Sadhasivam S, Myer CM 3rd. Preventing opioid-related deaths in children undergoing surgery. Pain Med 2012; 13: 982-983.
28. Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJ et al. ABCB1 hap-lotype and OPRM1 118A 4 G genotype interaction in methadone maintenance treatment pharmacogenetics. Pharmacogenomics Pers Med 2012; 5: 53-62.
29. Cook-Sather SD, Li J, Goebel TK, Sussman EM, Rehman MA, Hakonarson H. TAOK3, a novel genome-wide association study locus associated with morphine requirement and postoperative pain in a retrospective pediatric day surgery population. Pain 2014; 155: 1773-1783.
30. Jimenez N, Anderson GD, Shen DD, Nielsen SS, Farin FM, Seidel K et al. Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy. Paediatr Anaesth 2012; 22: 669-675.
31. Sadhasivam S, Krekels EH, Chidambaran V, Esslinger HR, Ngamprasertwong P, Zhang K et al. Morphine clearance in children: does race or genetics matter? J Opioid Manag 2012; 8: 217-226.
32. Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE et al. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmaco-genet Genomics 2010; 21: 152-161.
33. Kesimci E, Engin AB, Kanbak O, Karahalil B. Association between ABCB1 gene polymorphisms and fentanyl's adverse effects in Turkish patients undergoing spinal anesthesia. Gene 2012; 493: 273-277.
34. Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Tregouet D et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 2006; 79: 316-324.
35. Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 2008; 83: 559-566.
36. Leschziner GD, Andrew T, Pirmohamed M, Johnson MR. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J 2007; 7: 154-179.
37. Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet 2000; 356: 1667-1671.
38. Caraco Y. Genes and the response to drugs. N Engl J Med 2004; 351: 2867-2869.